SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 73.48 |
Enterprise Value ($M) | 24.67 |
Book Value ($M) | 197.91 |
Book Value / Share | 3.82 |
Price / Book | 0.37 |
NCAV ($M) | 164.03 |
NCAV / Share | 3.17 |
Price / NCAV | 0.45 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.24 |
Return on Assets (ROA) | -0.20 |
Return on Equity (ROE) | -0.23 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 13.98 |
Current Ratio | 13.98 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 189.62 |
Assets | 223.50 |
Liabilities | 25.59 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | PFM Health Sciences, LP | |||
13G/A | BML Investment Partners, L.P. | |||
13G | Sio Capital Management, LLC | |||
13G/A | ArrowMark Colorado Holdings LLC | 7.08 | 34.38 | |
13G/A | BlackRock, Inc. | 2.30 | -64.02 | |
13G/A | Jpmorgan Chase & Co | 0.00 | -99.58 | |
13G/A | Rtw Investments, Lp | 0.00 | -100.00 | |
13G/A | Avoro Capital Advisors LLC | 0.00 | -100.00 | |
13G/A | Citadel Advisors Llc | 2.40 | ||
13G/A | Boxer Capital, LLC | 0.00 | -100.00 | |
13G/A | Vanguard Group Inc | 4.70 | -12.65 | |
13G/A | State Street Corp | 1.41 | 11.89 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
5,501 | 123,066 | 4.47 | |
7,927 | 90,713 | 8.74 | |
14,651 | 507,198 | 2.89 | |
3,303 | 91,594 | 3.61 | |
(click for more detail) |
Similar Companies | |
---|---|
PHAT – Phathom Pharmaceuticals, Inc. | PHVS – Pharvaris N.V. |
PLRX – Pliant Therapeutics, Inc. | PRAX – Praxis Precision Medicines, Inc. |
PRLD – Prelude Therapeutics Incorporated |
Financial data and stock pages provided by
Fintel.io